Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222

TerminatedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

May 31, 2021

Primary Completion Date

November 24, 2021

Study Completion Date

November 24, 2021

Conditions
Coronavirus Disease 2019 (COVID-19)
Interventions
OTHER

None (Observational study)

The main data sources for the study will be participants and their medical records. Vaccination details will be verified by a vaccination card, batch/lot number, and/or using a regional vaccination register. Participants will report all study outcomes using the study app, web portal, or call centre. Participants can also select a proxy to communicate on their behalf: a caregiver, family member, or other trusted individual. Participants will be asked for an emergency contact in case of death or incapacity.

Trial Locations (1)

45355

Research Site, Essen

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY